In May 2013 and March 2015, actress Angelina Jolie wrote in the New York Times about her choice to undergo preventive surgery. In her two op-eds she explained that - as a carrier of the BRCA1 gene mutation - preventive surgery was the best way to lower her heightened risk of developing breast and ovarian cancer. By applying a digital methods approach to BRCA-related tweets from 2013 and 2015, before, during and after the exposure of Jolie’s story, this study maps and interprets Twitter discursive dynamics at two time points of the BRCA Twitter stream. Findings show an evolution in curation and framing dynamics occurring between 2013 and 2015, with individual patient advocates replacing advocacy organisations as top curators of BRCA content ...
Rapid and efficient communication regarding quickly evolving medical information was paramount for h...
Background: Since COVID-19 vaccines became broadly available to the adult population, sharp divergen...
BACKGROUND: Genetic testing, particularly for BRCA1/2, is increasingly important in prostate cancer ...
In May 2013 and March 2015, actress Angelina Jolie wrote in the New York Times about her choice to u...
Storytelling has long been used as a theoretical framework for understanding how we share informatio...
This is an Open Access article distributed under the terms of the Creative Commons Attribution Licen...
Background:The topic of breast cancer genetics entered the public discourse following Angelina Jolie...
In 2013 Angelina Jolie revealed in a New York Times editorial that she underwent a preventive double...
Twitter is one social media platform that enables those experiencing breast cancer to access support...
On May 14, 2013, Angelina Jolie disclosed she carries BRCA1, which means she has an 87% risk of deve...
Recently, Twitter has strongly promoted its service as a means of following the day-to-day activitie...
Despite the consensus in the medical discipline that certain treatments lack scientific evidence and...
Background: On 14 May 2013, Angelina Jolie (AJ), revealed herself to be the carrier of a BReast CAnc...
Objective. This study used digital surveillance to examine the impact of Angelina Jolie’s prophylact...
<p>Abstract copyright data collection owner.</p>This data collection consists of tweets in English t...
Rapid and efficient communication regarding quickly evolving medical information was paramount for h...
Background: Since COVID-19 vaccines became broadly available to the adult population, sharp divergen...
BACKGROUND: Genetic testing, particularly for BRCA1/2, is increasingly important in prostate cancer ...
In May 2013 and March 2015, actress Angelina Jolie wrote in the New York Times about her choice to u...
Storytelling has long been used as a theoretical framework for understanding how we share informatio...
This is an Open Access article distributed under the terms of the Creative Commons Attribution Licen...
Background:The topic of breast cancer genetics entered the public discourse following Angelina Jolie...
In 2013 Angelina Jolie revealed in a New York Times editorial that she underwent a preventive double...
Twitter is one social media platform that enables those experiencing breast cancer to access support...
On May 14, 2013, Angelina Jolie disclosed she carries BRCA1, which means she has an 87% risk of deve...
Recently, Twitter has strongly promoted its service as a means of following the day-to-day activitie...
Despite the consensus in the medical discipline that certain treatments lack scientific evidence and...
Background: On 14 May 2013, Angelina Jolie (AJ), revealed herself to be the carrier of a BReast CAnc...
Objective. This study used digital surveillance to examine the impact of Angelina Jolie’s prophylact...
<p>Abstract copyright data collection owner.</p>This data collection consists of tweets in English t...
Rapid and efficient communication regarding quickly evolving medical information was paramount for h...
Background: Since COVID-19 vaccines became broadly available to the adult population, sharp divergen...
BACKGROUND: Genetic testing, particularly for BRCA1/2, is increasingly important in prostate cancer ...